Belzutifan Combo Could be Second-Line Option in Advanced RCC

Published Date: 04 Mar 2026

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Read Full News

Latest News

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

'Concerning': CRC Continues to Shift Toward Younger Adults

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Todays Updates

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

'Concerning': CRC Continues to Shift Toward Younger Adults

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Latest News

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

News All Time

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.

PSMA PET: Prostate Cancer Staging Revolution Awaits RCT Data

‘Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

Researchers compared outcomes of stereotactic radiation and hippocampal-avoidance whole brain radiation in patients with 5-20 brain metastases.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

The all-oral, fixed-duration treatment combination provided better PFS and safety than investigator’s choice of chemoimmunotherapy in the phase 3 AMPLIFY study.

Prenatal Tylenol Use Drops, Leucovorin Prescriptions Surge

Prenatal Tylenol Use Drops, Leucovorin Prescriptions Surge

Doctors Tell MPs Corridor Care Is Driving Abuse of NHS Staff

Emergency doctors warned MPs that unsafe A&E conditions and corridor care are leaving staff exposed to rising violence.

Meningitis Risk for Young Adults With Chikungunya Vaccine

European safety committee advises product information update after review of a safety signal for aseptic meningitis following Ixchiq vaccination against chikungunya.

One-third Of Americans Cut Back on Other Expenses to Cover Healthcare in 2025, Survey Shows

Roughly one-third of Americans cut back on food, utilities or other daily expenses to pay for healthcare last year, research ⁠from the West Health-Gallup Center showed on...

Insulet Recalls Some Insulin Devices in US Over Leakage Risk

Insulet has recalled specific batches of its insulin-delivery pods in the ⁠U.S. after finding a manufacturing defect that could stop diabetic users from ⁠getting their full...

Social Risk Alerts Prompt Better Blood Pressure Control

The intervention also involves adding Z codes to patient records.

Psychosocial Risk: Loneliness as a Diabetes Predictor

Pooled results from nine cohorts of 1 million people show loneliness raises type 2 diabetes risk by 32%; asking ‘Do you feel lonely?’ could inform preventive care.

GLP-1 Persistence for Weight Loss Has Nearly Doubled

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

Intraperitoneal Insulin an Option for Select T1D Patients

An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable Infusion Pump might be considered appropriate.

Drugs Compared for Steroid-Linked Osteoporosis: What’s Best?

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

Reclassification From Type 2 to Type 1 Diabetes Not Uncommon

Those who were misdiagnosed had higher healthcare utilization, suggesting potential benefits of broader autoantibody screening.

Early Intensive Therapy Best for PsA With Poor Prognosis

Early intensive treatment for PsA with csDMARDs or 6 months of TNFi is superior to standard step-up care, and better outcomes were maintained at 48 weeks in the TNFi group.

Recommended News For You

Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Researchers discuss HER2-low and HER2-zero in breast cancer

Sports for girls are frequently abandoned due to uniform issues.

Using MRD Status to Deescalate Multiple Myeloma Therapy

A new FDA boxed warning; suicides rocking college campuses; more people getting flu shots than COVID vaccines.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

Recommended Articles For You

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis 

Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies 

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

2.

Can taking vitamin D supplements every day lower the mortality rate from cancer?

3.

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

4.

Thriving while surviving: Understanding the social needs of cancer survivors

5.

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

1.

Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning 

2.

Case Study: Genomic Medicine in Precision Oncology

3.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

4.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

5.

The Growing Challenge of Haematological Malignancies in Older Adults

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

2.

A New Era in Managing Cancer-Associated Thrombosis

3.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

4.

Navigating the Complexities of Ph Negative ALL - Part V

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot